These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2760480)

  • 1. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs.
    Katz JM; Webster RG
    J Infect Dis; 1989 Aug; 160(2):191-8. PubMed ID: 2760480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host cell-mediated variation in H3N2 influenza viruses.
    Katz JM; Naeve CW; Webster RG
    Virology; 1987 Feb; 156(2):386-95. PubMed ID: 3811239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic and structural characterization of multiple subpopulations of H3N2 influenza virus from an individual.
    Katz JM; Webster RG
    Virology; 1988 Aug; 165(2):446-56. PubMed ID: 3407150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of influenza virus A/H3N2 and B vaccines on the basis of cross-reactivity of postvaccination human serum antibodies against influenza viruses A/H3N2 and B isolated in MDCK cells and embryonated hen eggs.
    Kishida N; Fujisaki S; Yokoyama M; Sato H; Saito R; Ikematsu H; Xu H; Takashita E; Tashiro M; Takao S; Yano T; Suga T; Kawakami C; Yamamoto M; Kajiyama K; Saito H; Shimada S; Watanabe S; Aoki S; Taira K; Kon M; Lin JH; Odagiri T
    Clin Vaccine Immunol; 2012 Jun; 19(6):897-908. PubMed ID: 22492743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.
    Kodihalli S; Justewicz DM; Gubareva LV; Webster RG
    J Virol; 1995 Aug; 69(8):4888-97. PubMed ID: 7609057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs.
    Alymova IV; Kodihalli S; Govorkova EA; Fanget B; Gerdil C; Webster RG
    J Virol; 1998 May; 72(5):4472-7. PubMed ID: 9557744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells.
    Katz JM; Webster RG
    J Gen Virol; 1992 May; 73 ( Pt 5)():1159-65. PubMed ID: 1588320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
    Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
    Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses.
    Meyer WJ; Wood JM; Major D; Robertson JS; Webster RG; Katz JM
    Virology; 1993 Sep; 196(1):130-7. PubMed ID: 8356790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule.
    Wood JM; Oxford JS; Dunleavy U; Newman RW; Major D; Robertson JS
    Virology; 1989 Jul; 171(1):214-21. PubMed ID: 2741341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of key amino acid substitutions in the hemagglutinin of influenza A (H3N2) viruses on vaccine production and antibody response.
    Chen Z; Zhou H; Jin H
    Vaccine; 2010 May; 28(24):4079-85. PubMed ID: 20399830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes.
    Smith G; Liu Y; Flyer D; Massare MJ; Zhou B; Patel N; Ellingsworth L; Lewis M; Cummings JF; Glenn G
    Vaccine; 2017 Sep; 35(40):5366-5372. PubMed ID: 28844407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines.
    Nakowitsch S; Waltenberger AM; Wressnigg N; Ferstl N; Triendl A; Kiefmann B; Montomoli E; Lapini G; Sergeeva M; Muster T; Romanova JR
    Biotechnol J; 2014 Mar; 9(3):405-14. PubMed ID: 24323790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Immune Responses to and Cross-Protective Efficacy of Eurasian H7 Avian Influenza Viruses.
    Kwon HI; Kim YI; Park SJ; Song MS; Kim EH; Kim SM; Si YJ; Lee IW; Song BM; Lee YJ; Yun SJ; Kim WJ; Choi YK
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
    Levine MZ; Martin ET; Petrie JG; Lauring AS; Holiday C; Jefferson S; Fitzsimmons WJ; Johnson E; Ferdinands JM; Monto AS
    J Infect Dis; 2019 May; 219(12):1904-1912. PubMed ID: 30721982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvanted inactivated influenza A(H3N2) vaccines induce stronger immunogenicity in mice and confer higher protection in ferrets than unadjuvanted inactivated vaccines.
    Ann J; Samant M; Rheaume C; Dumas C; Beaulieu E; Morasse A; Mallett C; Hamelin ME; Papadopoulou B; Boivin G
    Vaccine; 2014 Sep; 32(43):5730-9. PubMed ID: 25173481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.